Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Bert Vander Cruyssen

Awards & Distinctions

71 Results

2018

Etanercept in patients with inflammatory hand osteoarthritis (EHOA) : a multicentre, randomised, double-blind, placebo-controlled trial

Margreet KloppenburgRoberta RamondaKlaus BobaczWing-Yee KwokDirk ElewautTom WJ HuizingaFeline PB KroonLeonardo PunziJosef S SmolenBert Vander Cruyssen et al.

A1 Journal Article in ANNALS OF THE RHEUMATIC DISEASES

2012

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

Martine De VosO DewitG D'HaensF BaertF FontaineS VermeireD FranchimontT MoreelsD StaessenL Terriere et al.

A1 Journal Article in JOURNAL OF CROHNS & COLITIS

Predictors of functional impairment and pain in erosive osteoarthritis of the interphalangeal joints: comparison with controlled inflammatory arthritis

Ruth WittoekBert Vander CruyssenAugust Verbruggen

A1 Journal Article in ARTHRITIS AND RHEUMATISM

Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints : a double blind, randomised trial on structure modification

August VerbruggenRuth WittoekBert Vander CruyssenDirk Elewaut

A1 Journal Article in ANNALS OF THE RHEUMATIC DISEASES

Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis

Martine De VosJ JahnsenJ VandervoortG D'haensO DewitE LouisD FranchimontF BaertR TorpP Potvin et al.

2011

Microscopic polyangiitis involving the breast

MIEKE DEVINCKBert Vander CruyssenKathleen LambeinFilip De KeyserMarleen PraetGuy Brusselle

A1 Journal Article in ACTA CLINICA BELGICA

Optimized alkylated cyclodextrin polysulphates with reduced risks on thromboembolic accidents improve osteoarthritic chondrocyte metabolism

Sara GroeneboerStijn LambrechtAad DhollanderPeggy JacquesBert Vander CruyssenRik J LoriesKatrien DevreeseKoen ChiersDirk ElewautAugust Verbruggen

A1 Journal Article in RHEUMATOLOGY

Predicting the outcome of ankylosing spondylitis therapy

Nathan VastesaegerDésirée van der HeijdeRobert D InmanYanxin WangAtul DeodharBenjamin HsuMahboob U RahmanBen DijkmansPiet GeusensBert Vander Cruyssen et al.

A1 Journal Article in ANNALS OF THE RHEUMATIC DISEASES

2010

Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis

Debby LaukensMichel GeorgesCécile LibioulleCynthia SandorMyriam MniBert Vander CruyssenHarald PeetersDirk ElewautMartine De Vos

A1 Journal Article in PLOS ONE

Health status and impact of pain : a comparative study between female patients with the Ehlers-Danlos syndrome, fibromyalgia and rheumatoid arthritis

Lies RombautFransiska MalfaitSTEVEN RIMBAUTBert Vander CruyssenAnne De PaepePatrick Calders

Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery

Bert Vander CruyssenElisa Muñoz-GomarizPilar FontJuan MuleroKurt de VlamAnnelies BoonenJanitzia Vazquez-MelladoDiana FloresNathan VastesaegerEduardo Collantes

A1 Journal Article in RHEUMATOLOGY

Morbid anatomy of 'erosive osteoarthritis' of the interphalangeal finger joints : an optimised scoring system to monitor disease progression in affected joints

August VerbruggenRuth WittoekBert Vander CruyssenDirk Elewaut

A1 Journal Article in ANNALS OF THE RHEUMATIC DISEASES

Reduced levels of the TGFB family member GDF15 in spondyloarthritis versus other rheumatic diseases

Stijn LambrechtFilip Van den BoschBert Vander CruyssenFilip De KeyserAugust VerbruggenDieter DeforceDirk Elewaut

Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease : attrition rate and evolution of disease activity

Bert Vander CruyssenPatrick DurezRene WesthovensFilip De Keyser

A1 Journal Article in ARTHRITIS RESEARCH & THERAPY

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies

Bert Vander CruyssenPatrick DurezRene WesthovensMarie-Joelle KaiserIlse HoffmanFilip De Keyser

A1 Journal Article in ARTHRITIS RESEARCH & THERAPY

2009

Classification models for disease: the effect of associations between markers on calculating the risk for disease by likelihood ratio products

Ruth WittoekFilip De KeyserA BoonenKurt de VlamNathan VastesaegerHerman MielantsBert Vander Cruyssen

A1 Journal Article in CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Clinical Observations programme in SpA: disease parameters, treatment options and practical management issues

Dirk ElewautFilip Van den BoschAugust VerbruggenFilip De KeyserBert Vander CruyssenHerman Mielants

A1 Journal Article in Rheumatology International

Cross-cultural adaptation of the Dutch version of the functional index for hand osteoarthritis (FIHOA)and a study on its construct validity

Ruth WittoekBert Vander CruyssenE MaheuAugust Verbruggen

A1 Journal Article in OSTEOARTHRITIS AND CARTILAGE

Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis

M GeorgesDebby LaukensC LibioulleC SandorM MniBert Vander CruyssenHarald PeetersDirk ElewautMartine De Vos

Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis

Katrien Van BenedenKen CoppietersW LaroyFilip De KeyserIlse HoffmanFilip Van den BoschBert Vander CruyssenMichael DrennanPeggy JacquesP Rottiers et al.

A1 Journal Article in ANNALS OF THE RHEUMATIC DISEASES

Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome

Annelies BoonenBert Vander CruyssenKurt de VlamSerge SteinfeldClio RibbensJan LenaertsFilip Van den BoschLode DewulfNathan Vastesaeger

A1 Journal Article in JOURNAL OF RHEUMATOLOGY

Validation of a new screening strategy for anti-extractable nuclear antigen antibodies

Jens Van PraetBert Vander CruyssenCarolien BonroyVanessa SmithJoris DelangheFilip De Keyser

A1 Journal Article in CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

2008

A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis

Pieter DewintValerie GossyeKarolien De BosscherWim Vanden BergheKatrien Van BenedenDieter DeforceSerge Van CalenberghU MULLER-LADNERBert Vander CruyssenAugust Verbruggen et al.

A1 Journal Article in JOURNAL OF IMMUNOLOGY

Clinical and genetic factors associated with sacroiliitis in Crohn's disease

Harald PeetersBert Vander CruyssenHerman MielantsKurt De VlamSeverine VermeireEdouard LouisPaul RurgeertsJacques BelaicheMartine De Vos

A1 Journal Article in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Cyclodextrin polysulphate protects articular cartilage in experimental lapine knee osteoarthritis

Sara GroeneboerP PASTOUREAUE VIGNONBert Vander CruyssenDirk ElewautAugust Verbruggen

A1 Journal Article in OSTEOARTHRITIS AND CARTILAGE

Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis

Bert Vander CruyssenL NOGUEIRAJens Van PraetDieter DeforceDirk ElewautG SERREFilip De Keyser

A1 Journal Article in ANNALS OF THE RHEUMATIC DISEASES

Epidemiology of hip involvement in ankylosing spondylitis

Bert Vander CruyssenE MUNOZ-GOMARIZP FONTJ MULEROKurt De VlamA BOONENW NOELN VASTESAEGER

Over-representation of construction-related occupations in male patients with systemic sclerosis

Vanessa SmithM. VanthuyneBert Vander CruyssenJens Van PraetF. VermeirenH. SmetsF. HoussiauFilip De Keyser

A1 Journal Article in Annals of the Rheumatic Diseases

Prediction models for disease: The effect of associations between markers on calculating the risk for disease by likelihood ratio products in SpA

Bert Vander CruyssenRuth WittoekA BOONENKurt De VlamN VASTESAEGERW NOELHerman MielantsFilip De Keyser

Reduced metallothionein expression in colonic Crohn's disease: evidence for a new disease-modifying gene

Debby LaukensHarald PeetersAnouk WaeytensSara BogaertBert Vander CruyssenDirk ElewautFilip De KeyserHerman MielantsClaude CuvelierKenny Knecht et al.

Reduced metallothionein expression in colonic Crohn's disease: evidence for it new disease-modifying gene

Debby LaukensHarald PeetersAnouk WaeytensSara BogaertBert Vander CruyssenDirk ElewautFilip De KeyserHerman MielantsClaude CuvelierP Van Hummelen et al.

Spontaneous amelioration in early RA: Role of antibody profiles in predicting decrease of disease activity

Bert Vander CruyssenAMM MILTENBURGFilip Van den BoschJ HOUBIERSRuth WittoekAMH BOOTSFilip De Keyser

Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population

Bert Vander CruyssenR WESTHOVENSP DUREZFilip Van den BoschHerman MielantsL DE CLERCKA PERETZM MALAISEL VERBRUGGENL DEWULF et al.

Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population

Bert Vander CruyssenR WESTHOVENSP DUREZL DE CLERCKA PERETZL VERBRUGGENN VASTESAEGERW NOELF DE KEYSER

Validation of a new screening strategy for anti-ENA antibodies

Jens Van PraetBert Vander CruyssenCarolien BonroyVanessa SmithJoris DelangheFilip De Keyser

Xylosan polysulphate as a symptom modifying osteoarthritis drug in patients with finger joint arthritis

Bert Vander CruyssenQ. MoqadamSara GroeneboerD. Cullis-HillP. GhoshAugust Verbruggen

2007

A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner

Ken CoppietersKatrien Van BenedenPeggy JacquesPieter DewintAnn VervloetBert Vander CruyssenSerge Van CalenberghGuangwu ChenRichard FranckAugust Verbruggen et al.

A1 Journal Article in JOURNAL OF IMMUNOLOGY

Osteochondral repair in synovial joints

August VerbruggenRuth WittoekSara GroeneboerBert Vander CruyssenStefan GoemaereDirk Elewaut

A1 Journal Article in CURRENT OPINION IN RHEUMATOLOGY

Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis

Bert Vander CruyssenLieve NuytinckLuc BoullartDirk ElewautWillem WaegemanMira Van ThielenE. DE MEESTERK. LEBEERR. ROSSAUFilip De Keyser

A1 Journal Article in RHEUMATOLOGY

Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis and may have an added value in prediction models

Bert Vander CruyssenLieve NuytinckFilip De Keyser

The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice

Bert Vander CruyssenClio RibbensAnnelies BoonenHerman MielantsKurt De VlamJan LenaertsSerge SteinfeldFilip Van den BoschLode DewulfNathan Vastesaeger

A1 Journal Article in ANNALS OF THE RHEUMATIC DISEASES

2006

Altered gut transcriptome in spondyloarthropathy

Debby LaukensHarald PeetersBert Vander CruyssenTom BoonefaesDirk ElewautFilip De KeyserHerman MielantsClaude CuvelierEric VeysKenny Knecht et al.

A1 Journal Article in ANNALS OF THE RHEUMATIC DISEASES

Clinical assessment in the spondyloarthropathies, including psoriatic arthritis

Filip Van den BoschBert Vander CruyssenHerman Mielants

A1 Journal Article in CURRENT OPINION IN RHEUMATOLOGY

Comparison of the anti-human citrullinated fibrinogen antibodies assayed by ELISA with 2 other ACPA assays: Diagnostic value and agreement between assays

Bert Vander CruyssenL NOGUEIRATineke CantaertC CAVELLEEN DE RYCKEM SEBAGDieter DeforceDirk ElewautG SERREFilip De Keyser

Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays

Bert Vander CruyssenTineke CantaertL NOGUEIRAC CLAVELLEEN DE RYCKEA DENDOVENM SEBAGDieter DeforceC VINCENTDirk Elewaut et al.

A1 Journal Article in ARTHRITIS RESEARCH & THERAPY

Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition

Bert Vander CruyssenR WESTHOVENSP DUREZFilip Van den BoschHerman MielantsL DE CLERCKA PERETZM MALAISEL VERBRUGGENN VASTESAEGER et al.

Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity

Bert Vander CruyssenStijn Van LooyBart WynsR WESTHOVENSP DUREZFilip Van den BoschHerman MielantsL DE CLERCKA PERETZM MALAISE et al.

A1 Journal Article in ARTHRITIS RESEARCH & THERAPY

Markers and outcome measures in chronic immune mediated artrhritis: from association studies to prediction models.

Bert Vander CruyssenF De Keyser

Modeling the probability for rheumatoid arthritis during diagnostic work-up: How to combine the results of ACPA, RF and HLA-SE testing?

Bert Vander CruyssenIlse HoffmanIsabelle PeeneAnn UnionHerman MielantsL MEHEUSF DE KEYSER

Polymorphisms in the ficolin 1 gene (Fcn1) are associated with susceptibility to the development of rheumatoid arthritis

Bert Vander CruyssenLieve NuytinckFilip De Keyser

Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment

Stijn Van LooyBert Vander CruyssenJeroen MeeusBart WynsR WESTHOVENSP DUREZFilip Van den BoschN VASTESAEGERA GELDHOFLuc Boullart et al.

A1 Journal Article in ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE

Radiological sacroiliitis in Crohn's disease: A multicenter association study

Harald PeetersBert Vander CruyssenHerman MielantsKurt De VlamS VERMEIREE LOUISP RUTGEERTSJ BELAICHEMartine De Vos

The diagnostic value of the anti-human citrullinated fibrinogen antibodies by elisa compared to anti-CCP2 antibodies, and their agreement with ACPA detected by 3 other substrates

Bert Vander CruyssenL NogueiraT CantaertC CavelLies De RyckeM SebagDieter DeforceDirk ElewautG SerreFilip De Keyser

Which patients with ankylosing spondylitis start anti-TNF-alpha therapy in daily clinical practice?

Bert Vander CruyssenHerman MielantsA BOONENJ LENAERTSE LESAFFREKurt De VlamC RIBBENSS STEINFELDFilip Van den BoschN VASTESAEGER et al.

2005

A plant-derived compound with fully dissociated properties on glucocorticoid receptor-mediated gene regulation

R DEWINTK DE BOSSCHERW VANDEN BERGHEBert Vander CruyssenEric VeysG HAEGEMANDirk Elewaut

Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis

Bert Vander CruyssenIlse HoffmanHans-Georg ZmierczakMarthe Van Den BergheElli KruithofLeen De RyckeHerman MielantsEric VeysDominique BaetenFilip De Keyser

A1 Journal Article in ANNALS OF THE RHEUMATIC DISEASES

Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor

Bert Vander CruyssenIsabelle PeeneTineke CantaertIlse HoffmanLeen De RyckeEric VeysFilip De Keyser

A1 Journal Article in AUTOIMMUNITY REVIEWS

CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease

Debby LaukensHarald PeetersDENIS MARICHALBert Vander CruyssenHerman MielantsDirk ElewautPieter DemetterClaude CuvelierM VAN DEN BERGHEPieter Rottiers et al.

A1 Journal Article in ANNALS OF THE RHEUMATIC DISEASES

CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients

Bert Vander CruyssenHarald PeetersIlse HoffmanDebby LaukensPaul CouckeDENIS MARICHALClaude CuvelierErik RemautEric VeysHerman Mielants et al.

A1 Journal Article in CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Comparing statistics with machine learning models to predict dose increase of infliximab for rheumatoid arthritis patients

Stijn Van LooyBert Vander CruyssenBart WynsJeroen MeeusFilip De KeyserLuc Boullart

Comparison of Machine Learning models for prediction of dose increase in patients with rheumatoid arthritis

Stijn Van LooyJeroen MeeusBart WynsBert Vander CruyssenLuc BoullartFilip De Keyser

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment

Bert Vander CruyssenStijn Van LooyBart WynsR WESTHOVENSP DUREZM MALAISEL VERBRUGGENN VASTESAEGERA GELDHOFLuc Boullart et al.

A1 Journal Article in ARTHRITIS RESEARCH & THERAPY

DAS28 is a robust measure of the physician's clinical judgment of response infliximab therapy

Bert Vander CruyssenStijn Van LooyBart WynsR WESTHOVENSP DUREZF VAN DEN BOSHEric VeysHerman MielantsLISELOTTE DE CLERCKA PERETZ et al.

Das28 correlates best with the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients

Bert Vander CruyssenStijn Van LooyR WESTHOVENSP DUREZFilip Van den BoschEM VEYSL DE CLERCKA PERETZM MALAISEJ DEVOGELAER et al.

Feature selection in the prediction of Infliximab dose increase

Stijn Van LooyJeroen MeeusBart WynsBert Vander CruyssenFilip De KeyserLuc Boullart

Mannose-binding lectin (Mbl2) polymorphisms in rheumatoid arthritis are not associated with susceptibility, radiological progression rate, or serological markers

Leen De RyckeIsabelle PeeneElli KruithofIlse HoffmanBert Vander CruyssenJ JURASL NUYTINCKEric VeysFilip De Keyser

Potent anti-inflammatory, fully dissociative compound for glucocorticoid receptor-mediated gene regulation

Pieter DewintKarolien De BosscherValerie GossyeWim Vanden BergheBert Vander CruyssenEric VeysGuy HaegemanDirk Elewaut

2004

Radiological sacroiliitis is linked with CARD15 gene polymorphisms in patients with Crohn's disease

Bert Vander CruyssenHarald PeetersDebby LaukensP COUCKEHerman MielantsMartine De VosFilip De Keyser

Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease

Harald PeetersBert Vander CruyssenDebby LaukensPaul CouckeDENIS MARICHALMARTINA VAN DEN BERGHEClaude CuvelierErik RemautHerman MielantsFilip De Keyser et al.

A1 Journal Article in ANNALS OF THE RHEUMATIC DISEASES

The presence of CARD15 polymorphisms is linked with higher ASCA titers in Crohn's disease

Harald PeetersBert Vander CruyssenDebby LaukensP COUCKEIlse HoffmanFilip De KeyserMartine De Vos

2003

Crohn's disease patients with CARD15 variants have higher risk of developing axial joint involvement

Martine De VosHarald PeetersBert Vander CruyssenDebby LaukensDenis MarichalMarthe VandenbergheT Van OostveldtDirk ElewautFilip De KeyserClaude Cuvelier et al.